BCIQ Profiles

Company Profile Report
0830 Laronde series B
BioCentury & Getty Images

Product Development

Laronde putting infrastructure ahead of INDs, leveraging $400M series B for hiring spree

Flagship’s closed-loop RNA company aims to partner after reaching modality “unlocks” 

Aug 31, 2021 | 1:42 AM GMT

Having incubated its long-lasting RNA technology for four years, Flagship-founded Laronde is using its $400 million series B round to industrialize its platform before picking

Read the full 638 word article

How to gain access

Continue reading with a
two-week free trial.